- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0005136

Indcon Pharma Limited
About Indcon Pharma Limited
Data last updated:
Indcon Pharma Limited is a public limited company based in New Delhi, Delhi, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 08 March 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85110DL2002PLC114517. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.56 Lakh. It is led by directors including Divya Misra and Prabhas Narain Misra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 9/6 Okhla Indl. Area Phase – I, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2020, the company reported a revenue of ₹39 Lakh, a growth of 104% compared to the previous year. For the same year it recorded a net profit of ₹31.22 Lakh (net margin 80%) and EBITDA of -₹1.63 Lakh (EBITDA margin -4.2%).
Indcon Pharma Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0005136). The current compliance status is marked as compliant by the Registrar of Companies.
Recognitions & Rankings of Indcon Pharma
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD – 9/6 Okhla Indl. Area Phase – I, New Delhi, Delhi, India – 110020
- IndustryHealthcare, Human Health Activities, Specialized Hospitals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Indcon Pharma Limited
FY 2025 filings availableIndcon Pharma Limited reported revenue of ₹39 Lakh (up 104% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 104% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2015-16 to FY 2018-19in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | ₹39 Lakh | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | -₹1.63 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹31.22 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2019-20 | FY 2015-16 to FY 2018-19in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -4.2% | |
| Net Profit Margin | 80% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2015-16 to FY 2018-19, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Indcon Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Indcon Pharma Limited
Indcon Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Divya Misra Also directs: Psa Nitrogen Limited, Indcon Boilers Limited | Director | 09 Sep 2009 | 17 Years 1 Months | Current |
| Prabhas Narain Misra Also directs: Psa-Kc Desiccants LLP, Psa Nitrogen Limited, Psa Air Products (India) Private Limited and 3 more | Director | 08 Mar 2002 | 24 Years 7 Months | Current |
| Usha Rani Misra Also directs: Psa Nitrogen Limited, Psa Air Products (India) Private Limited, FGD Engineering Private Limited and 2 more | Director | 08 Mar 2002 | 24 Years 7 Months | Current |
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Indcon Pharma Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Indcon Pharma.
: available in the company report
Recent Activity
Indcon Pharma Limited has 3 board changes on record since 2002: 3 appointments. The latest: Divya Misra was appointed as Director on 09 Sep 2009.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Indcon Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Indcon Pharma is an active public limited company based in New Delhi, Delhi, India. The company works in human health activities, within the healthcare industry. It was incorporated on 08 March 2002 (24+ years old) and is registered under CIN U85110DL2002PLC114517.
Indcon Pharma has 3 current directors:
- Divya Misra - Director
- Prabhas Narain Misra - Director
- Usha Rani Misra - Director
The latest financial statements of Indcon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Indcon Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Indcon Pharma is U85110DL2002PLC114517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indcon Pharma was incorporated on 08 March 2002, making it 24+ years old. It is registered with the Registrar of Companies, Delhi.
Divya Misra was appointed as Director on 09 Sep 2009. Prabhas Narain Misra was appointed as Director on 08 Mar 2002. Usha Rani Misra was appointed as Director on 08 Mar 2002.
Yes, Indcon Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0005136).
The registered office of Indcon Pharma is at D – 96 Okhla Indl. Area Phase – I, New Delhi, Delhi, India – 110020.
Indcon Pharma operates in the healthcare industry, in the human health activities segment.